Strategic Collaboration Leverage the existing Goodwill Pharma partnership and the long-standing collaboration to position HENNIG as a preferred contract development and manufacturing organization for complex solid dosage forms and customized packaging, offering expanded OEM or private-label opportunities.

Niche Therapeutic Focus Target opportunities in vertigo, sleep disorders, hypertension and related CNS and cardiovascular segments where HENNIG has established expertise, offering specialized formulations, generics, and differentiating patient-ready solutions for healthcare providers and pharmacies.

Domestic-to-Export Growth Explore expansion into adjacent European markets leveraging HENNIG’s traditional strength in German pharmaceutical manufacturing, focusing on contract manufacturing capacity, regulatory support, and scalable production for small to mid-size regional brands seeking reliable supply partners.

Add-on Services Promote end-to-end services including feasibility studies, development up to full service, with emphasis on modified-release solid dosage forms, coating, extrusion and packaging capabilities to attract pharma companies needing turnkey CNS and CV product launches.

SME Partnership Potential Position HENNIG as a cost-effective, agile partner for mid-market pharma and nutraceuticals seeking contract manufacturing and private-label products, emphasizing quick scale-up from lab to industrial scale and customer-specific service packages.